- Advertisement -

Young blood may hold the key to treating age-related diseases

In what sounds like a scene from a science fiction movie, researchers in 2005 stitched together old and young mice so they shared a...

Why Was Vir Biotechnology Up 74% in February? – Nasdaq

What happened Shares of Vir Biotechnology (NASDAQ: VIR) jumped 74.6% in February, according to data provided by S&P Global Market Intelligence. In fact, the entire year...

“Skeleton Key” T-Cell Receptor Works across Multiple Cancer Types

Anticancer T-cell therapy has a lot in common with lock picking, a painstaking business that often ends in frustration. Every cancer, like every lock,...

Benefits of PCR-Based Molecular Diagnostics

In vitro diagnostics (IVD) is an umbrella term for tests conducted on blood or tissue samples to detect diseases, determine the efficacy of novel...

Promising new technique for high throughput protein purification

Jun 25 2019 Postnova Analytics has published an application report that describes a promising new protein purification technique based on diffusion. Related Stories Protein purification is...

New approach shows promise in fighting multiple cancers

The tissue adjacent to a tumor behaves differently than areas farther away: The tumor's cancerous cells influence their surroundings, blocking the body's immune defenses...

Thermo Fisher Agrees to Acquire Sanofi’s Steriles Manufacturing Site

Thermo Fisher Scientific signed an agreement to acquire Sanofi’s steriles manufacturing site in Ridgefield, NJ, and will continue to manufacture a portfolio of therapies...

Targeting GLUD1 shows promise in restoring muscle function in Duchenne muscular...

New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse...

Thermo Fisher Agrees to Acquire Sanofi’s Steriles Manufacturing Site

Thermo Fisher Scientific signed an agreement to acquire Sanofi’s steriles manufacturing site in Ridgefield, NJ, and will continue to manufacture a portfolio of therapies...

Targeting GLUD1 shows promise in restoring muscle function in Duchenne muscular dystrophy

New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse...

Gut Microbiota Metabolite Could Point to Atherosclerosis Diagnostics, Therapeutics

Cardiovascular disease is the leading cause of death worldwide and often originates in atherosclerosis, a chronic condition in which inflammation and fat deposits cause...

more new items

Thermo Fisher Agrees to Acquire Sanofi’s Steriles Manufacturing Site

Thermo Fisher Scientific signed an agreement to acquire Sanofi’s steriles manufacturing site in Ridgefield, NJ, and will continue to manufacture a portfolio of therapies...

Targeting GLUD1 shows promise in restoring muscle function in Duchenne muscular...

New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse...

Gut Microbiota Metabolite Could Point to Atherosclerosis Diagnostics, Therapeutics

Cardiovascular disease is the leading cause of death worldwide and often originates in atherosclerosis, a chronic condition in which inflammation and fat deposits cause...